COLACI, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.378
EU - Europa 10.971
AS - Asia 4.910
SA - Sud America 717
AF - Africa 103
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 34.103
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.227
IT - Italia 5.009
GB - Regno Unito 2.887
SG - Singapore 1.588
CN - Cina 1.562
SE - Svezia 801
HK - Hong Kong 710
BR - Brasile 580
DE - Germania 514
UA - Ucraina 428
TR - Turchia 345
FR - Francia 325
RU - Federazione Russa 283
FI - Finlandia 243
VN - Vietnam 236
BG - Bulgaria 135
NL - Olanda 131
ID - Indonesia 97
KR - Corea 80
IN - India 75
CA - Canada 72
AR - Argentina 65
MX - Messico 57
ZA - Sudafrica 49
JP - Giappone 46
PL - Polonia 31
BD - Bangladesh 25
IE - Irlanda 25
AE - Emirati Arabi Uniti 24
BE - Belgio 22
EC - Ecuador 21
ES - Italia 21
RO - Romania 20
IR - Iran 18
CH - Svizzera 17
IQ - Iraq 17
LT - Lituania 15
MA - Marocco 15
AU - Australia 14
BZ - Belize 14
MY - Malesia 14
CL - Cile 12
VE - Venezuela 10
AT - Austria 8
CO - Colombia 8
EG - Egitto 8
KE - Kenya 8
SA - Arabia Saudita 8
TN - Tunisia 8
EU - Europa 7
JO - Giordania 7
NO - Norvegia 7
AZ - Azerbaigian 6
BO - Bolivia 6
HU - Ungheria 6
PE - Perù 6
BY - Bielorussia 5
CZ - Repubblica Ceca 5
GR - Grecia 5
IL - Israele 5
NP - Nepal 5
PH - Filippine 5
PK - Pakistan 5
PY - Paraguay 5
HR - Croazia 4
KG - Kirghizistan 4
OM - Oman 4
TW - Taiwan 4
LU - Lussemburgo 3
MD - Moldavia 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
UY - Uruguay 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
KZ - Kazakistan 2
LB - Libano 2
PA - Panama 2
QA - Qatar 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GY - Guiana 1
IM - Isola di Man 1
Totale 34.089
Salva come PNG Salva come JPEG
Città #
Southend 2.236
Fairfield 1.826
Santa Clara 1.544
Ashburn 1.172
Woodbridge 1.068
Singapore 1.037
Houston 840
Chandler 751
Jacksonville 725
Chicago 719
Hong Kong 706
Seattle 685
Wilmington 621
Cambridge 599
Ann Arbor 532
Dearborn 502
Los Angeles 471
Nyköping 425
Hefei 369
Milan 351
Rome 350
London 340
Salt Lake City 307
Beijing 278
Izmir 221
Modena 208
New York 169
Tampa 160
San Diego 148
Princeton 139
Sofia 132
Elk Grove Village 131
Helsinki 127
Eugene 123
Dallas 104
The Dalles 102
Council Bluffs 94
Florence 91
Naples 89
Bologna 85
Palermo 79
Ho Chi Minh City 77
Jakarta 77
Shanghai 76
Sterling 75
Seoul 74
Bremen 73
Redwood City 72
Buffalo 71
Catania 68
Des Moines 65
Hanoi 64
Moscow 64
Bari 63
Turin 63
Frankfurt am Main 57
Columbus 56
Lancaster 54
San Jose 54
São Paulo 52
Genoa 51
Guangzhou 44
Verona 44
Detroit 43
Miami 43
Atlanta 41
Padova 41
Phoenix 38
Dulles 37
Boardman 35
Cagliari 32
Norwalk 31
Munich 30
Tokyo 28
Kunming 27
Falls Church 26
Johannesburg 23
Salerno 23
Denver 22
Parma 22
Pittsburgh 22
Mexico City 21
Pisa 21
Dong Ket 20
Dublin 20
Brescia 19
Kansas City 19
Reggio Emilia 19
Toronto 19
Warsaw 19
Belo Horizonte 18
Brooklyn 18
Amsterdam 17
Chiswick 17
Delhi 17
Hounslow 17
Jersey City 17
Legnano 16
Messina 16
Nanjing 16
Totale 22.960
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.717
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 865
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 737
Semeiotica dell'articolazione temporo-mandibolare 488
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 406
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 396
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 389
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 380
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 356
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 351
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 345
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 339
Endocrine manifestations of hepatitis C virus infection. 338
Thymus alterations and systemic sclerosis 334
Heart involvement and systemic sclerosis 330
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 328
Scleroderma digital ulcers complicated by infection with fecal pathogens. 321
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 321
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 319
Current treatment of hepatitis C-associated rheumatic diseases. 308
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 306
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 304
Aortic pulse wave velocity measurement in systemic sclerosis patients. 303
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 301
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 300
L-Arginine in pregnant scleroderma patients 300
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 298
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 293
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 292
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 292
Elevated Troponin Serum Levels in Adult Onset Still's Disease 287
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 286
Platelet gel in the treatment of severe scleroderma skin ulcers. 283
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 283
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 282
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 281
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 279
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 277
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 277
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 268
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 263
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 261
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 258
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 257
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 256
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 255
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 255
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 254
Cardiovascular risk and prostanoids in systemic sclerosis 252
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 250
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 248
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 247
Associations between Systemic Sclerosis and Thyroid Diseases 245
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 240
New targeted molecular therapies for dedifferentiated thyroid cancer 236
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 234
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 233
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 233
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 231
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 231
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 228
HCV-related rheumatic manifestations and therapeutic strategies 228
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 226
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 225
Renal Manifestations of Hepatitis C Virus 222
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 222
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 220
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 220
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 218
Treatment of HCV-related mixed cryoglobulinemia 218
The safety of iloprost in systemic sclerosis in a real-life experience 218
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 217
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 214
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 213
IP-10 in autoimmune thyroiditis 211
Novel Therapies for Thyroid Autoimmune Diseases 210
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 208
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 207
[CXCR3 and CXCL10 in autoimmune thyroiditis] 205
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 201
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 198
Osteomyelitis complicating scleroderma digital ulcers. 197
ADULT ONSET STILL'S DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY OF 233 ITALIAN PATIENTS 194
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis. 190
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 190
Mixed cryoglobulinemia syndrome: where are we going to? 189
CXCL10 in psoriasis 189
Severe alopecia complicating systemic sclerosis 189
Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis. 189
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 188
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 184
Serum a-Chemokine CXCL10 and b-Chemokine CCL2 Levels in HCV-Positive Cryoglobulinemia 183
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 182
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 182
RET TKI: potential role in thyroid cancers. 181
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 174
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 171
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard. 171
Trattamento del dolore in reumatologia con oppioidi: nostra esperienza con ossicodone in pazienti con ulcere cutanee vasculitiche. 166
Trattamento con Rituximab in pazienti con vasculite crioglobulinemica. 163
Totale 30.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 134.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.511
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.592 0 0 0 0 0 481 429 560 169 398 330 225
2021/20222.636 114 259 280 204 100 181 140 135 280 223 390 330
2022/20233.426 395 246 182 231 401 421 209 307 426 133 299 176
2023/20243.048 134 196 196 345 503 260 290 308 88 185 236 307
2024/20256.012 290 120 152 487 1.193 891 405 320 624 321 601 608
2025/20266.515 490 303 670 1.711 2.855 486 0 0 0 0 0 0
Totale 34.389